Search by Drug Name or NDC
NDC 49884-0213-74 Alprazolam 1 mg/1 Details
Alprazolam 1 mg/1
Alprazolam is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is ALPRAZOLAM.
MedlinePlus Drug Summary
Alprazolam is used to treat anxiety disorders and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Alprazolam is in a class of medications called benzodiazepines. It works by decreasing abnormal excitement in the brain.
Related Packages: 49884-0213-74Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Alprazolam
Product Information
| NDC | 49884-0213 |
|---|---|
| Product ID | 49884-213_80d3cefb-e83e-4dbd-ba6e-2eac42ccc73f |
| Associated GPIs | 57100010007215 |
| GCN Sequence Number | 058849 |
| GCN Sequence Number Description | alprazolam TAB RAPDIS 1 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 24373 |
| HICL Sequence Number | 001617 |
| HICL Sequence Number Description | ALPRAZOLAM |
| Brand/Generic | Generic |
| Proprietary Name | Alprazolam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | alprazolam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/1 |
| Substance Name | ALPRAZOLAM |
| Labeler Name | Par Pharmaceutical, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA078088 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49884-0213-74 (49884021374)
| NDC Package Code | 49884-213-74 |
|---|---|
| Billing NDC | 49884021374 |
| Package | 10 BLISTER PACK in 1 CARTON (49884-213-74) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Marketing Start Date | 2009-01-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |